D-0446-2024 Class II

Recalled by Specialty Process Labs LLC — Phoenix, AZ

FDA drug recall D-0446-2024 was initiated by Specialty Process Labs LLC on Mar 1, 2024 and is designated Class II. Reason for recall: Failed Stability Specifications Affected quantity: 26 units.

Recall details

Product Type
Drugs
Report Date
Apr 24, 2024
Initiation Date
Mar 1, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
26 units

Product description

S.P.Labs, Thyroid, Full Strength, Rx only, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-500-01.

Reason for recall

Failed Stability Specifications

Distribution pattern

U.S. Nationwide.

Code information

Lot #: H22212-FSV, Exp: 11/21/2024 1.0 kg pack size.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0446-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0446-2024. Report a data issue: hello@regdatalab.com.